Advertisement

Topics

Galena Biopharma merges SELLAS to form new combined company

19:00 EDT 9 Aug 2017 | Pharmaceutical Technology

SELLAS Life Sciences Group has entered an all-stock definitive merger agreement, under which the company will merge into and become an indirect, wholly owned subsidiary of US-based Galena Biopharma.

Original Article: Galena Biopharma merges SELLAS to form new combined company

NEXT ARTICLE

More From BioPortfolio on "Galena Biopharma merges SELLAS to form new combined company"

Quick Search
Advertisement
 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...